Nanjing Vishee Medical Technology Co (SHSE:688580) Total Stockholders Equity : ¥1,648.9 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Nanjing Vishee Medical Technology Co Total Stockholders Equity?

Nanjing Vishee Medical Technology Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥1,648.9 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Nanjing Vishee Medical Technology Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥17.22. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Nanjing Vishee Medical Technology Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.00.

Nanjing Vishee Medical Technology Co Total Stockholders Equity Historical Data

The historical data trend for Nanjing Vishee Medical Technology Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Vishee Medical Technology Co Total Stockholders Equity Chart

Nanjing Vishee Medical Technology Co Annual Data

Trend

Dec13

Dec14

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

249.25

1,406.02

1,533.06

1,528.55

1,626.76

Nanjing Vishee Medical Technology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															1,553.86	1,550.06	1,588.91	1,626.76	1,648.86

Nanjing Vishee Medical Technology Co (SHSE:688580) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Nanjing Vishee Medical Technology Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1648.864	-	0)	/	95.7713
	=	17.22

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Nanjing Vishee Medical Technology Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	1648.864
	=	0.00

Nanjing Vishee Medical Technology Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Nanjing Vishee Medical Technology Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanjing Vishee Medical Technology Co (SHSE:688580) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanjing Vishee Medical Technology Co Ltd (SHSE:688580) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 19 Ningshuang Road, Building 9, Yuhuatai District, Nanjing, CHN, 210012

Website

http://www.vishee.com

Nanjing Vishee Medical Technology Co Ltd is engaged in production and sales of rehabilitation medical devices. The company's products under Pelvic floor and postpartum rehabilitation include Pelvic floor electromyography biofeedback instrument; Myotrac series biological stimulation feedback instrument; Ruiyi Series Biostimulation Feedback Apparatus; Magneuro Series Magnetic Stimulator; Female psychological rehabilitation; Neonatal electroencephalograph; Consumables; and under Mental rehabilitation include Multi-parameter biofeedback instrument; Group biofeedback; Magneuro Series Magnetic Stimulator; and Cognitive dysfunction treatment software.

Executives

Huang He	Senior management, core technical personnel
Chou Kai	Senior management, core technical personnel
Zhong Yi Qun	senior management
Chen Li Li	Directors, senior managers
Zhang Hui	senior management
Gao Fei	Core technical personnel
Lian Qing Ming	Director

Nanjing Vishee Medical Technology Co (SHSE:688580) Headlines

No Headlines